Peginterferon-α 2B plus ribavirin is more effective than peginterferon-α 2A plus ribavirin in menopausal women with chronic hepatitis C
Journal of Viral Hepatitis, 08/10/2012
Clinical Article
Villa E et al. – The higher SVR rate with Peg–IFNα–2b in menopausal women is likely attributable to more favourable pharmacokinetics that allows Peg–IFNα–2b to reach visceral fat and oppose the increased cytokine production and enhanced inflammatory status in menopause.



